Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
DH
$0.64
-0.23%
DH · Definitive Healthcare Corp.
$0.64
0.00 (-0.23%)
At close · Aug 14
Market Cap
$68.23M
Shares
106.74M
All earnings calls
Earnings call · FY2026 Q2
Definitive Healthcare Corp. Q2 FY2026 Earnings Call
Definitive Healthcare Corp. Q2 FY2026 Earnings Call
Forward guidance
12 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$55.20M
-9.1% YoY
Diluted EPS
-$0.05
Gross margin
73.5%
-3.2 pp YoY
Net income
-$5.42M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 10, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenue
Third Quarter 2026
|
$54M – $55M | — | |
|
Adjusted Operating Income
Third Quarter 2026
|
$10.5M – $11.5M | Non-GAAP | |
|
Adjusted EBITDA Margin
Third Quarter 2026
|
25% – 27% | Non-GAAP | |
|
Adjusted Net Income
Third Quarter 2026
|
$5.5M – $6.5M | Non-GAAP | |
|
Adjusted EBITDA
Third Quarter 2026
|
$13.5M – $14.5M | Non-GAAP | |
|
Adjusted Net Income Per Diluted Share
Third Quarter 2026
|
$0.04 – $0.05 | Non-GAAP | |
|
Revenue
Full Year 2026
|
$220M – $222M | — | |
|
Adjusted Operating Income
Full Year 2026
|
$45.5M – $47.5M | Non-GAAP | |
|
Adjusted Net Income
Full Year 2026
|
$27M – $29M | Non-GAAP | |
|
Adjusted EBITDA Margin
Full Year 2026
|
26% – 27% | Non-GAAP | |
|
Adjusted Net Income Per Diluted Share
Full Year 2026
|
$0.18 – $0.20 | Non-GAAP | |
|
Adjusted EBITDA
Full Year 2026
|
$57M – $59M | Non-GAAP |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 10, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 10, 2026 · complete as-filed document